StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3046% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Medpace's revenue for the twelve months ending Sep 30, 2026 was $2.84B, up 20.4% year over year. For fiscal 2025 it was $2.53B, up 20.0% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $2.53B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.53B+20.0%
FY2024Dec 31, 2024$2.11B+11.8%
FY2023Dec 31, 2023$1.89B+29.2%
FY2022Dec 31, 2022$1.46B+27.8%
FY2021Dec 31, 2021$1.14B+23.4%
FY2020Dec 31, 2020$925.93M+7.5%
FY2019Dec 31, 2019$860.97M+22.2%
FY2018Dec 31, 2018$704.59M+61.5%
FY2017Dec 31, 2017$436.15M+3.5%
FY2016Dec 31, 2016$421.58M+17.4%
FY2015Dec 31, 2015$359.06M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$716.00M+8.5%
Q2 FY2026Jun 30, 2026$707.33M+17.2%
Q1 FY2026Mar 31, 2026$706.60M+26.5%
Q4 FY2025Dec 31, 2025$708.45M+32.0%
Q3 FY2025Sep 30, 2025$659.90M+23.7%
Q2 FY2025Jun 30, 2025$603.31M+14.2%
Q1 FY2025Mar 31, 2025$558.57M+9.3%
Q4 FY2024Dec 31, 2024$536.59M+7.7%
Q3 FY2024Sep 30, 2024$533.32M+8.3%
Q2 FY2024Jun 30, 2024$528.10M+14.6%
Q1 FY2024Mar 31, 2024$511.04M+17.7%
Q4 FY2023Dec 31, 2023$498.40M+26.5%
Q3 FY2023Sep 30, 2023$492.50M+28.3%
Q2 FY2023Jun 30, 2023$460.87M+31.2%
Q1 FY2023Mar 31, 2023$434.07M+31.2%
Q4 FY2022Dec 31, 2022$394.10M+27.7%
Q3 FY2022Sep 30, 2022$383.74M+29.8%
Q2 FY2022Jun 30, 2022$351.21M+26.2%
Q1 FY2022Mar 31, 2022$330.95M+27.3%
Q4 FY2021Dec 31, 2021$308.55M+18.8%
Q3 FY2021Sep 30, 2021$295.57M+28.3%
Q2 FY2021Jun 30, 2021$278.29M+35.8%
Q1 FY2021Mar 31, 2021$259.97M+12.6%
Q4 FY2020Dec 31, 2020$259.68M+13.0%
Q3 FY2020Sep 30, 2020$230.37M+6.5%
Q2 FY2020Jun 30, 2020$205.00M-4.3%
Q1 FY2020Mar 31, 2020$230.88M+15.0%
Q4 FY2019Dec 31, 2019$229.89M+19.7%
Q3 FY2019Sep 30, 2019$216.24M+20.6%
Q2 FY2019Jun 30, 2019$214.10M+25.8%
Q1 FY2019Mar 31, 2019$200.74M+23.1%
Q4 FY2018Dec 31, 2018$192.12M+70.5%
Q3 FY2018Sep 30, 2018$179.25M+62.0%
Q2 FY2018Jun 30, 2018$170.14M+60.2%
Q1 FY2018Mar 31, 2018$163.08M+53.0%
Q4 FY2017Dec 31, 2017$112.68M+18.1%
Q3 FY2017Sep 30, 2017$110.64M–
Q2 FY2017Jun 30, 2017$106.22M–
Q1 FY2017Mar 31, 2017$106.61M–
Q4 FY2016Dec 31, 2016$95.38M–

More Medpace figures

See a number that looks wrong?